Literature DB >> 8433961

Treating hypertensive emergencies. Controlled reduction of blood pressure and protection of target organs.

L M Prisant1, A A Carr, D W Hawkins.   

Abstract

Diastolic blood pressure of 120 mm Hg or more is often cited as identifying a hypertensive crisis. However, the absolute level of blood pressure may not be as important as the rate of increase. One important feature that distinguishes hypertensive emergency from hypertensive "urgency" is the ongoing vascular damage that occurs with hypertensive emergency. When this is present, therapy should be initiated as soon as possible. The initial goal is to reduce mean arterial pressure about 15% to 25% within the first 48 hours. Overzealous or uncontrolled reduction in blood pressure may result in coma, stroke, myocardial infarction, acute renal failure, or death. Thus, a drug with titratable dosing (eg, intravenous nitroprusside sodium [Nipride, Nitropress]) is preferred in most situations. Patients with hypertensive urgency do not have evidence of vascular damage. Usually, they are asymptomatic, have no retinal lesions, and have a marked elevation in diastolic blood pressure. Hypertensive urgency does not require immediate normalization of blood pressure, but initiation of therapy and careful follow-up are critical.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433961     DOI: 10.1080/00325481.1993.11701601

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  8 in total

Review 1.  Current and newer agents for hypertensive emergencies.

Authors:  Alan Padilla Ramos; Joseph Varon
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 2.  Clinical overview of hypertensive crisis in children.

Authors:  Wen-Chieh Yang; Mao-Jen Lin; Chun-Yu Chen; Han-Ping Wu
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

3.  The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema.

Authors:  W Schreiber; C Woisetschläger; M Binder; A Kaff; H Raab; M M Hirschl
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

4.  Guidelines for the drug treatment of hypertensive crises.

Authors:  M M Hirschl
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

Review 5.  Aortic dissection.

Authors:  L Michael Prisant; V R Prasad Nalamolu
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-06       Impact factor: 3.738

6.  Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review.

Authors:  W Frank Peacock; Jorge E Angeles; Karina M Soto; Philip D Lumb; Joseph Varon
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

7.  Ophthalmoscopic findings in malignant hypertension.

Authors:  Stephen Hammond; Jill Razor Wells; Dennis M Marcus; L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-03       Impact factor: 3.738

Review 8.  Clinical review: the management of hypertensive crises.

Authors:  Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2003-07-16       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.